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Abstract 
   
Newly developed live-attenuated protease derivative from pathogenic Vibrio harveyis train Vh1 as a live vaccine to against Vibriosis of aquatic 
animals. In the current study, we used the gnotobiotic A. salina as model to evaluate the safety and efficacy of the live-attenuated. This study was 
conducted by bacterial safety experiment and bacterial efficacy experiment. During the bacterial safety, the wild type and live-attenuated of V. 
harveyi (MVh-vhs) were tested for 48 hours on the Artemia larvae (instar II). During the efficacy experiment, the A. salina larvae were incubated 
with different concentration of live-attenuated V. harveyi (MVh-vhs), then challenged with V. harveyi, V. alginolyticus and V. 
parahaemolyticus. The result of safety experiment showed that the high concentration of live-attenuated mutant V. harveyi (MVh-vhs) at 
concentration of 109 CFU/mL is safe and had improved the A. salina larvae survival compared to other groups. On the other hand, pathogenic 
wildtype V. harveyi caused lethal effect on A. salina larvae by decreasing their survival. The surprising result of efficacy experiment showed that 
107 CFU/mL of live attenuated MVh-vhs with 6 hours post incubation withA. salina larvae contributed higher survival while 109 CFU/mL of live 
attenuated MVh-vhs with 24 hours incubated A. salina larvae contributed higher survival against multiple Vibrio challenge. In this study, we 
concluded that the incubation time had affect bacterial concentration uptake by A. salina larvae and affect the effectiveness of Artemia 
bioencapsulation for targeted hosts.  
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Introduction 
Artemia sp. is characterize as having a short life-span 
with good resilience and able to survive in high 
salinity environment which is suitable as good model 
organisms to study virulence of marine pathogenic 
bacteria (Lee et al., 2014). In fact, A. salina is a small 
crustacean species which highly depending on the 
innate immune system that consists of cellular 
components and humoral components due to lacking 
of adaptive immune system (Soderhall and Lee, 2002; 
Hauton, 2012). Similar with other invertebrates, 
cellular and humoral mechanisms contribute defense 
reaction through preventing microbial invasions or 
assisting the elimination of the invading microbes in 
their bodies (Destoumieux-Garzon et al., 2001). 
Moreover, during early stages of fish growth 
development including the developing embryos until 
further larval stages are all rely on innate immune 
system to regulate quick immune responses and 
protect the host against unfavorable condition 
(Vadstein et al., 2013). Therefore, A. salina larvae can 
be a pathogen-disease study model for all live stages 
of marine crustacean and early developing life stages 
of marine fishes because they all have similar immune 
system. Live Artemia nauplii have been used as 
vectors for delivering compounds to larvae stages of 
aquatic animals, which known as bioencapsulation. 
Moreover, bacteria with various characteristics had 
been incorporated into Artemia nauplii and this route 
has been used to vaccinate fry.  
 
Vibriosis is a disease caused by pathogenic Vibrio 
spp. that has negatively affected worldwide marine 
aquaculture by increase mortality of farmed fishes 
and potentially zoonotic to human (Haenen et al., 
2014; Aris et al., 2018). Vibrio species including V. 
harveyi, V. alginolyticus and V. parahaemolyticus 
are few of the major species that cause vibriosis in 
marine crustacean shrimp, Penaeus vannamei and P. 
monodon (Chatterjee and Haldar, 2012) and marine 
finfish such as large yellow croaker, 
Pseudosciaenacrocea (Liu et al., 2016). On the other 
hand, the fact that seawater is a reservoir of Vibrios, 
water transmission is suggested as another primary 
route for Vibrio infection in aquatic organisms, 
collapsing the first physical and chemical defense 
barrier when the bacteria penetrates the wounded or 
exposed skin (Frans et al., 2011).Previously, our 
laboratory has successfully constructed a live-
attenuated serineprotease vaccine by genetically 
modified a local isolate of virulent V. harveyi (Aris et 
al., 2018). The novel live vaccine candidate namely V. 
harveyi strain MVh-vhswas constructed by site 
directed mutagenesis, conjugation and allelic 
exchange (Aris et al., 2018).  
 
Moreover, non-selective filter feeding of A. salina 
nauplii (Instar II) was used for bioencapsulation and 
become vector of Vibriosp (Interaminense et al., 
2014). Therefore, the current experiments to evaluate 
the bioencapsulation and safety of live attenuated V. 
harveyi strain MVh-vhs on gnotobiotic A. salina 
larvae (Instar II of nauplii) by immersion method.  
 
Materials and Methods 
Gnotobiotic Artemia sp. culture 
Axenic A. salina nauplii were obtained by 
decapsulation and hatching procedures. 0.2 g of 
commercial Artemia cysts (O.S.I. PRO 80TM Brine 
shrimp cysts) were hydrated with 18 L of tap water for 
an hour of strong aeration in sterile falcon tube. The 
following steps were then undertaken in sterile 
condition at which 10 ml of 50% cold NaOCl and 0.66 
ml of 32% NaOH were added to the hydrated cysts 
suspension for decapsulation and sterilization. After 
that, the sterilized decapsulated cyst suspension was 
then transferred to new sterile falcon tube equipped 
with a 0.22 µm-filtered aeration. Later, 14 ml of 
sodium thiosulphate was added to remove chlorine 
residue and the cysts were sieved with 100 µm mesh 
size and washed over by using sterile autoclaved 
seawater. The cysts were then transferred into new 
sterile falcon tube with 30 ml of sterile autoclaved 
seawater. The strong filtered aeration was supplied 
and waited for 24 hours to hatch. The newly hatched 
Artemiawere then continue growing for another 6 to 
8 hour to let the nauplii grow into instar ii of nauplii 
in sterile condition (referred as gnotobiotic larvae). 
Axenic confirmation was performed by plating 
Artemia naupliion TSA (Tryptic Soy Agar). No 
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bacteria growth on the agar indicates the success of 
gnotobiotic Artemia culture.  
 
Identification of Vibrio spp. strain and culture 
conditions 
Vibrio spp. were retrieved from glycerol stock stored 
at -80 °C or slant culture, followed by streaked plate 
on the TSA agar supplemented with 1.5% NaCl. The 
plates were incubated at 28 °C for 16 hours.For 
identifying the wildtype strain of V. alginolyticus and 
V. parahaemolyticus, DNA gyrase subunit B (gyrB) 
was targeted during PCR amplification (Table 1).  For 
the characterization of wildtype V. harveyi (VH1) 
strain and live-attenuated V. harveyi (MVh-vhs) 
strain, serine protease gene (VHS) was targeted 
during PCR amplification (Table 2) and the identity of 
the gene sequence was re-confirmed using nucleotide 
BLAST in NCBI database. The three bases deletion 
(D153, H123 and S228) on VHS of MVh-vhs was 
checked by using gene sequence alignment software, 
BioEditTM.  
 
The Vibrios were cultured on either tryptic soy agar 
(TSA) supplemented with 1.5% NaCl or thiosulfate 
citrate bile salts sucrose (TCBS) agar and the plates 
were incubated at 28 °C for 24h. A colony of the vibrio 
was re-inoculated into tryptic soy broth (TSB) 
supplemented with 1.5% NaCl and incubated with at 
28 °C for 24 hours. After that, the broth containing 
the bacteria was centrifuged at 12000 rpm for 15 min 
at 28°C. The concentration of bacteria solution was 
determined by spectrophotometrically at 600 nm 
(OD600) with McFarland standard calculation 
method. List of the Vibrio spp. used for experiment is 
shown in Table 3.  
 
Brine shrimp larvae survival studies 
Two separate experiments were performed to assess 
the safety and efficacy of the live attenuated vaccine 
in cultured A. salina larvae (Instar II).  
 
In the first experiment was aimed to study the dose-
response relationship of wildtype strain V. 
harveyi(VH1) and live-attenuatedV. harveyi (MVh-
vhs) inA. salina larvae survival. For each vibrio, 20 of 
A. salina larvae (Instar II) were initially transferred 
into sterile falcon tubes containing 25 ppt of sterile 
autoclaved seawater. The A. salina larvae were 
incubated with three different concentrations (105 
CFU/mL, 107 CFU/mL and 109 CFU/mL) of wildtype 
V. harveyi (VH1) strain and live-attenuated V. 
harveyi (MVh-vhs) strain into 30 mL of final volume. 
For the control treatment, no bacteria were added in 
the A. salina culture. All falcon tubes were placed 
horizontally on a rotor at 50 rpm at 24°C. Each 
treatment was performed in triplicate. The survival of 
A. salina larvae was observed at 12th hour, 24th hour, 
36th hour and 48th hour of incubation time. During 
observation, the suspension was poured into sterile 
petri dish, and was poured back into their respectively 
Falcon tube after observation under laminar flow 
hood. For estimating the survival, the number of 
swimming larvae were counted followed by 
calculating the survival percentage.  
 
The second experiment was studied to verify the 
protective effect of Bioencapsulated live attenuated V. 
harveyi (MVh-vhs) into A. salina larvae with two 
incubation time which is 6 hours and 24 hours on 
different concentrations (105 CFU/mL, 107 CFU/mL 
and 109 CFU/mL). Each set was conducted by 300 A. 
salina larvae were transferred into sterile falcon tubes 
consisting sterile autoclaved seawater. Then, the 
larvae were incubated initially with three different 
concentrations (105 CFU/mL, 107 CFU/mL and 109 
CFU/mL) of live-attenuated strain V. harveyi (MVh-
vhs) into final volume of 30 mL for the pre-
determined duration of incubation (6 hours or 24 
hours). After incubation, the 20 of swimming larvae 
were collected and transferred into sterile falcon 
tubes that contain sterile autoclaved seawater.  
 
The encapsulated A. salina larvae were challenged 
with wildtype V. harveyi (VH1) strain at 
concentration of 109 CFU/mL for 48 hours. The 
amount of spent medium transferred into each 
treatment was balanced by adding a complementary 
autoclaved seawater to make up the final volume of 
30mL and the falcon tubes were added horizontally 
on a rotor at 50 rpm at 24 °C. Triplicate for each 
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treatment was performed.The survival of larvaewere 
observed at 12th hour, 24th hour, 36th hour and 48th 
hour after challenge test at which the suspension was 
poured into sterile petri dish and later was poured 
back into their respective falcon tube after the 
observation under laminar flow hood. After that, the 
survival percentage was determined.  
 
The experiment were repeated for V. alginolyticus 
(VA2) and V. parahaemolyticus (FORC) challenge for 
cross-protective effect test. Non-encapsulated 
gnotobiotic A. salina larvae were used for the Vibrio 
spp. challenge for negative control. On the other 
hand, the encapsulated A. salina larvae without 
Vibrio sp. challenge for positive control. 
 
Data analysis 
The differences in survival were analyzed by one-way 
analysis of variance (ANOVA) with post-hoc Turkey 
test in IBM SPSS® software.  
 
The data was transformed into Arc-Sin and express as 
average ± stdev. The values were considered 
significantly different if p < 0.05 
Results 
Effect of live-attenuated V. harveyi (MVH-VHS) and 
wild type V. harveyi (VH1) on survival of A. salina 
larvae 
Fig. 1 shows the survival of Artemia larvae incubated 
with different concentration of liveattenuated V. 
harveyi (MVh-vhs) and wildtype V. harveyi (VH1) 
compared to the untreated group. According to Fig. 1 
(A), no significant differences (p<0.05) were observed 
on the survival of A. salina larvae incubated with 105 
CFU/mL bacteria and those in the control group. 
Insignificant larvae survival between treatments was 
maintained even at prolong incubation with 48 to 
62% larvae were survived at 48th hour incubation.  
 
In Fig. 1 (B), A. salina larvae treated with live 
attenuated V. harveyi(MVh-vhs)at 107 CFU/mL has 
significantly (p>0.05) improved the survival of A. 
salina larvae compared to the larvae that were 
immersed with wildtype V. harveyi (VH1) and control 
at 36th hour to 48th hour incubation. However, in 
Figure 1 (C) shown Immersion of Live attenuated V. 
harveyi (MVh-vhs) improved high survival 
performance of A. salina larvae.  
 
Table 1. Primers used for the PCR amplification. 
Primer Primer Sequence (5’ to 3’) Expected sizes (bp) Reference 
Serine protease (VHS)    
F_vhs GGTACCATGAAAAAACCATTGCTTGCG 1368 Aris et al., 2018 
 R_vhs GAGCTCTTAGCGGATAACGAGGTAAAC 
    
DNA gyrase subunit B (gyrB)    
F_gyrB GAGAACCCGACAGAAGCGAAG 332 Chatterjee and 
Haldar, 2012 R_gyrB CCTAGTGCGGTGATCAGTGTTG 
 
This proved by the performance of A. salina larvae 
were tested with live attenuated V. harveyi (MVh-
vhs) significantly higher (p>0.05) than both tested by 
Wildtype V. harveyi and control from 36th hour to 
48th hour.  
 
Efficacy of live-attenuated V. harveyi (MVh-vhs) on 
A. salina survival against V. harveyi, V. alginolyticus 
and V. parahaemolyticus 
In the second experiment, protective ability of live-
attenuated V. harveyi was investigated against 
different wild type of Vibriosfor A. salina larvae 
challenge. There are two trials with different live-
attenuated V. harveyi (MVH-vhs) incubation time 
which are 6 hours and 24 hours that indicated by Fig. 
2 and Fig. 3 respectively.  
 
Fig. 2 demonstrated the result for the survival of A. 
salina larvae after 6 hours pre-treated with different 
concentration of live-attenuated V. harveyi 
(MVh_vhs) and challenge with V. harveyi (VH1), V. 
alginolyticus (VA2) and V. parahaemolyticus (FORC-
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_008). After 6 hours encapsulation, administration of 
concentration 105 and 107 CFU/mL of live attenuated 
V. harveyi (MVh_vhs) gave poor significant different 
(p<0.05) in the challenged A. salina survival at 48th 
hour. However, In Fig. 3. After 24 hours 
encapsulation, administration of concentration 105 
and 107 CFU/mL of live attenuated V. harveyi 
(MVh_vhs) gave no significant different (p<0.05) but 
109 CFU/mL contributed significantly (p<0.05) high 
survival in the challenged A. salina survival at 48th 
hour.
 
Table 2. The deletion bases in catalytic sites of serine protease gene (VHS) sequence of MVh-vhs strain. (Source: 
Aris, unpublished). 
Target Bases for deletion Gene sequence (5’ to 3’) 
Aspartate (D153) GAGACGAGATGTCAgacATTGCCTTGCTTAAG 
Histidine (H123) ATCGTAACGAACTATcacGTTATCAAAGGCGC 
Serine (S228) CAATTAACAGTGGTAACtccGGTGGCGCTT 
Note: the small capital with underline indicate a target deletion in specific catalytic gene. 
 
Table 3.  Bacteria strains that used for the experiment. 
Bacteria Relevant characteristic Source or Reference 
Vibrio harveyi 
Strain VH1 
Strain MVh-vhs 
 
 
Complete serine endoprotease gene (VHS) 
3 base deletion of DNA sequence on deficit serine 
endoprotease gene (VHS) 
GenBank:KT266880.1, Aris et al. 2016. 
Isolation from Brown marbled grouper, 
Epinephelusfuscoguttatus 
Aris et al., 2018 (Unpublished) 
Lab collection 
Vibrio alginolyticus 
Strain VA2 
A strain of V. alginolyticus GenBank:KU141337.1 
Nehlah, Ina-Salwany&Zulperi, 2016. 
Isolation from Brown marbled grouper, 
Epinephelusfuscoguttatus 
Vibrio parahaemolyticus 
Strain FORC_008 
A strain of V. parahaemolyticus GenBank:CP013826.1 
Isolation from Brown marbled grouper, 
Epinephelusfuscoguttatus 
 
In this experiment, the strain significantly increased 
the survival of A. salina larvae that encapsulated 109 
CFU/ML of live attenuated V. harveyi (MVh_vhs) 
strain for 24 hours encapsulation after challenged 
withthree Vibriosp. 
 
Therefore, administration of Live-attenuated V. 
harveyi (MVh_vhs) at the concentration 109 
CFU/ML for 24 hours encapsulation in A. salina 
larvae provided the best protection from vibriosis.  
 
Discussion 
The results showed that the live-attenuated V. 
harveyi (MVh-vhs) is not only safe and harmless for 
A. salina larvae but also can recover their survival at 
prolong incubation of 36 h to 48 h. Previous studies 
showed that the same live-attenuated V. harveyi 
(MVh-vhs) at three different concentrations 105 
CFU/mL, 107 CFU/mL and 109 CFU/mL as vaccine 
candidates was harmless for tiger grouper juvenile,  
Epinephelusfuscoguttatus(Aris, 2018 Unpublished). 
This is possible due to loss of pathogenic and 
virulence factor of serine endoprotease gene which 
was attenuated in the Vibrio strain. Serine protease 
gene (VHS) for pathogenic V. harveyi has contributed 
as chaperone or provide thermal resistant properties 
for activity of proteolytic enzymes (Aris et al., 2016). 
Therefore, the live-attenuated V. harveyiMVh-vhsis 
harmless for A. salina larvae. Live-attenuated V. 
harveyi (MVh-vhs) was developed previously based 
on deletion of three catalytic amino acids sites 
including Aspartate (D153), Histidine (H123) and 
Serine (S228) of the bacterial serine protease gene 
(VHS) (Aris et al., 2016).  
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Fig. 1. Bacterial safety assay of Vibrio harveyi at different concentrations against Artemia salina. (A): A. salina 
larvae survival at 105cfu/mL of Vibrio spp. (B): A. salina larvae survival at 107cfu/mL of Vibrio spp. (C):A. salina 
larvae at 109cfu/mL of both Vibrio spp. , live-attenuated V. harveyi (MVh-vhs); , wildtype V. harveyi 
(VH1); and , control. Different superscript letter above the bar graph indicated significant differences 
(p<0.05). 
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According to Fig. 1, 107 CFU/mL and 109 CFU/mL 
bacterial concentration of live-attenuated V. harveyi 
(MVh-vhs) treatments contributed to higher survival 
of A. salina larvae compared to the wildtype V. 
harveyi (VH1) treatment and control treatment 
throughout the experiment period. Survival of A. 
salina larvae had improved possibly due to A. salina 
larvae consume the bacteria as their food because 
certain bacteria contribute nutritional value and 
positive effect of the growth rate as well as survival for 
Artemia spp. (Tkavc et al., 2010) Obviously, high 
concentrations of live-attenuated V. harveyiMVh-vhs 
(at 107 and 109cfu/mL) were more effective in 
improving the survival of A. salinalarvae.  
 
The concentration of bacterial suspension has shown 
to have effect on the accumulated bacteria quantity in 
Artemia spp. (Makridis et al., 2000). Furthermore, 
the effectiveness of Artemia nauplii bioencapsulation 
depends on targeted bacteria type, exposure time and 
status of Artemia nauplii (Gomez-Gill et al., 1998).  
 
In this study, the harmless live-attenuated V. harveyi 
(MVh-vhs) has high potential for use as bio-
encapsulated vaccine by encapsulate the A. salina.  
 
Based on experimental result of bacterial protective 
efficacy assay with A. salina larvae (Fig. 2 and 3), the 
live-attenuated V. harveyi (MVh-vhs) was 
encapsulated within the A. salina to test its 
protectivity against wildtype V. harveyi(VH1). 
Besides, V. alginolyticus (VA2) and V. 
parahaemolyticus (FORC) were used also to test on 
cross-protectivity of the live-attenuated V. harveyi 
(MVh-vhs) for A. salina larvae. Similar to Fig. 1, the 
high survival of A. salina larvae incubated with MVh-
vhs without the Vibro challenge in positive controls 
was recorded in this experiment throughout the 
experiment period. However, there is no surprise that 
low survival of A. salina larvae for negative control 
which was challenged by wildtype of Vibrio sp. We 
investigated the optimum incubation time of A. salina 
larvae with live-attenuated V. harveyi (MVh-vhs) to 
win over the infection by Vibrio spp. effectively. 
However, there are different time required for 
encapsulation or enrichment of gnotobiotic Artemia 
sp. larvae were used by researchers to test their 
different probiotic or immune-stimulant substance on 
their experiments. For example, active or autoclaved 
Bacillus sp. LT3 was incubated 6 hours with 
gnotobiotic Artemia sp. larvae for V. campbellii 
challenge test (Niu et al., 2014).  
 
The probionts, Lactobacillus acidophilus, L. 
sporogenes and yeast, Saccharomyces cerevisiae 
were incubated 24 hours with Artemia sp. larvae 
respectively for V. parahaemolyticus and V. cholerae 
challenge tests (Immanuel, 2016).  
 
According to Fig. 2, the result showed good 
performance for larvae survival when 107 CFU/mL of 
6h pre-incubated MVh-vhs at which it has improved 
A. salina larvae survival after challenge with 
109cfu/mL wildtype V. alginolyticus (VA2) and V. 
parahaemolyticus (FORC) respectively.  
 
The mechanism of live-attenuated V. harveyi (MVh-
vhs) for improving survival of A. salina larvae is still 
unknown against Vibrio challenge. However, there 
are possible reasons which can explain the ability of 
MVh-vhs to confer protection and cross-protection to 
the Artemia larvae as demonstrated in the current 
experiment. Firstly, the live attenuated V. harveyi 
(MVh-vhs) enhanced the A. salina immune response 
possibly through prevention of the rapid reproduction 
of pathogens by seizing the available resources 
including nutrients, space, adhesion sites on the A. 
salina larvae’ guts or surface etc. or secondly, through 
production of toxic or inhibitory substances to against 
pathogens (Marques et al., 2005). Artemia spp. are 
lack of adaptive immune system and fully depend on 
innate immune system of which recognized the 
pathogen associated molecules to activate cellular or 
humoral effector mechanisms to eliminate invasive 
pathogens (Vazquez et al., 2009).  
 
The other possible reason to such results is the 
Artemia spp. larvae’ tolerance to infection is 
enhanced due to stimulation of their non-specific or 
innate immune response (Sung et al., 2009). 
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Fig. 2. Survival upon 109 CFU/mL of Vibriospp challenge for 105 CFU/mL, 107 CFU/mL and 109 CFU/mL of 
Live-attenuated V. harveyi (MVh-vhs) with 6 hours encapsulated A. salina larvae respectively. A: V. harveyi 
(VH1) challenge test. B: V. alginolyticus (VA2) challenge test. C: V. parahaemolyticus (FORC_008) challenge 
test. , Positive control; , Negative control; , 105 CFU/mL of live-attenuated V. harveyi (MVh-vhs) 
incubation; , 107 CFU/mL of live-attenuated V. harveyi (MVh-vhs); and , 109 CFU/mL of live-attenuated 
V. harveyi (MVh-vhs) incubation respectively. Different superscript letter above the bar graph indicated 
significant differences (p<0.05). 
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Note that the live attenuated strain of bacteria as 
vaccine deliver foreign antigen to stimulate both 
innate immune system and activate adaptive immune 
system against infectious diseases (Shahabi et al., 
2010).  
 
In this experiment, the live-attenuated V. harveyi 
(MVh-vhs) also showed cross-protective potential for 
A. salina to against V. alginolyticus(VA2) and V. 
parahaemolyticus (FORC). Although the cross-
protective effect was not understood, the possible 
reason is V. harveyi, V. parahaemolyticus and V. 
alginolyticus are closely related that recognized as 
members of Harveyi clade which are subset of Vibrios 
core group (Lin et al., 2010). This might also related 
to the successful previous study which showed that 
formalin killed V. anguillarium can be cross-
protected for Banana shrimp, 
Fenneropenausmerguiensis via oral vaccination to 
against V. harveyi challenge (Patil et al., 2013).  
 
Nevertheless, the A. salina survival performance for 
107 CFU/ml of the live-attenuated V. harveyi (MVh-
vhs) with 24 hours pre-incubation seems not enough 
to confer protection to the larvae after multiple Vibrio 
challenge as shown in Figure 3. Previous study proved 
that non-pathogenic V. alginolyticus CW8T2 
contributed to a relatively lower biomass production 
that indicated nutrient value, body length and 
survival compare with other non-pathogenic bacteria 
strains for axenic Artemia juveniles (Verschuere et 
al., 1999).  
 
Therefore, we postulated that the nutrient value of 
MVh-vhs is similar with the other Vibrio sp. and are 
considered low for A. salina metabolism and the 
concentration of 107 CFU/mL might be insufficient 
for larvae survival which affected indirectly on their 
overall stimulated immune response. The pre-
incubation time are some significant factors for 
bioencapsulation of live bacteria supporting the 
statement made by Gomez-Gill et al. (1998). 
 
In support to that, other authors claimed that the 
higher concentration of particles, the higher the 
percentage of particles filled in the Artemia digestive 
tract (Gelabert, 2003). In this experiment, A. salina 
larvae are proved as Bioencapsulation vector on live-
attenuated V. harveyi(MVh-vhs) for other targeted 
organisms due to harmless if the bacteria.  
 
In fact, Artemiasp were commonly exploited in 
vaccine development due to their characteristic of 
bacterial consumption and encapsulation (Mutoloki 
et al. 2015). Besides, although the live-attenuated V. 
harveyi (MVh-vhs) that more likely to categorise as a 
type of vaccine candidate, but we believe will have 
similar characteristic and functions as probiotic since 
they are genetic modified bacteria. Actually, 
microorganisms included pathogens that used for 
undergoing genetic modification into harmless strain 
can be fully new probiotics (Steidler 2003). Moreover, 
Artemia bioencapsulation effectiveness on live-
attenuated V. harveyi (MVh-vhs) can be indicated by 
the survival of A. salina larvae after multiple Vibriosp 
challenge.  
 
This is because improvement of Artemia immune 
system due to probiotics retention during 
encapsulation can convey the probiotic for the main 
targeted host organism (Hai, Buller and Fotedar 
2010). Previous studies showed that Artemia 
bioencapsulation with formalin killed V. anguillarum 
vaccine protected antigens during digestion to trigger 
immune response of juvenile carp, Cyprinus carpio 
and gilthead seabream, Sparus aurata via oral 
administration (Joosten et al., 1995). 
 
In contrast, the Fig. 3 showed that the 24h pre-
incubation with high concentration (109 CFU/mL) of 
MVH-vhs contributed to significant high larvae 
survival than other treatment after the challenge test 
with high concentration 109 CFU/ml of multiple 
Vibrio. The survival showed the effect of pre-
incubation time needed for live attenuated V. harveyi 
(MVh-vhs) encapsulation that might contributed to 
the effectiveness of vaccination. Bioencapsulation is 
said to depends on targeted bacteria type, exposure 
time and status of Artemia sp. nauplii (Gomez-Gill et 
al., 1998).  
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Fig. 3. Survival upon 109 CFU/mL of Vibrio spp challenge for 105 CFU/mL, 107 CFU/mL and 109 CFU/mL of 
Live-attenuated V. harveyi (MVh-vhs) with 24 hours encapsulated A. salina larvae respectively. A: V. harveyi 
(VH1) challenge test. B: V. alginolyticus (VA2) challenge test. C: V. parahaemolyticus (FORC_008) challenge 
test. , Positive control; , Negative control; , 105 CFU/mL of live-attenuated V. harveyi (MVh-vhs) 
incubation; , 107 CFU/mL of V. harveyi(MVh-vhs); and , 109 CFU/mL of live-attenuated V. harveyi 
(MVh-vhs) incubation respectively. Different superscript letter above the bar graph indicated significant 
differences (p<0.05). 
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Previously similar study showed that the survival of 
Artemia sp. larvae that were exposed for shorter time 
(less than 8 hours) to mnn9 yeast cells had decreased 
gradually after V. campbellii challenge (Soltanian et 
al., 2007). Fig. 2 showed that, high concentration 109 
CFU/mL of the live-attenuated V. harveyi (MVh-vhs) 
incubated A. salina larvae with 6 hours contributed to 
significant lower survival than negative control after 
challenge with 109 cfu/mL wildtype V. harveyi (VH1) 
and no significant different with negative control after 
challenge with 109cfu/mL wildtype V. alginolyticus 
(VA2) and V. parahaemolyticus (FORC) respectively. 
In this experiment, we figured that 24 hours is the 
most suitable and recommended pre-incubation time 
compared to 6 hours. Therefore, A. salina might 
could not fully activate the immune defence 
mechanism in a short period to withstand the 
accumulation of high concentration of bacteria 
followed by Vibrio spp. challenge. There is similar 
previous research shows that lowest survival of 
Artemia spp. larvae after incubated with 1010 
CFU/mL of harmless probiotic yeast, S. cerevisiae 
suspension for 6 hours (Fazeli and Azari-Takami, 
2006). 
 
Conclusion 
In a nutshell, concentration of live-attenuated V. 
harveyi (MVH) and incubation time are very crucial 
key factors for enhancing immune system of Artemia 
larvae as model during multiple Vibrio challenge. We 
believe that have immune-enhance potential as 
vaccine candidate for short term protection on other 
marine crustacean and early stages of marine fishes 
which shared similar innate immunity in the future. 
Therefore, further biomolecular studies are suggested 
will improve understanding of the actual immune 
mechanisms behind.  Based on the experiment,  we 
concluded that 6 hours incubation time is most 
suitable for 107 CFU/mL of A. salina larvae with live-
attenuated V. harveyi (MVh-vhs) because sustainable 
cost-effective and time-effective for Artemia 
bioencapsulation as oral vaccination or its 
administration on the targeted animals directly to 
against effectively on high concentration of multiple 
Vibrios challenge.  
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